483
Exquisite CorporationExquisite Corporation – FDA 483, Apr 26, 2023
Record Details
Exquisite Corporation, a contract drug manufacturer in Baldwin Park, CA, was cited for significant deficiencies in its quality control unit, stability program, production and process controls, and equipment maintenance. The inspection revealed a lack of defined responsibilities for the quality unit, inadequate testing and validation practices, and insanitary conditions. These issues indicate a serious breakdown in the firm's pharmaceutical quality system.
View Company Profile
ID · 17dcb0ad-d2dc-49a6-820f-28ed7a1c5723
Other documents for Exquisite Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.